article thumbnail

Vaccines and various response rates

Drug Discovery World

It is these lymph nodes which help to make proteins called antibodies that protect from infection. In research, it allows us to directly study vaccine-responsive cells, for example their genomic composition and protein expression. KP: Lymph nodes are small bean-shaped organs and there are hundreds throughout the body.

article thumbnail

Moderna’s FDA COVID-19 Vaccine Adcom is Thursday, and Expectations are High

The Pharma Data

ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Both use mRNA, which codes for a portion of the virus’s spike protein. Only two days after the first viral genome was mapped and published in early January, Moderna had finalized their vaccine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Clinical Catch-Up: January 18-22 | BioSpace

The Pharma Data

It includes adults with confirmed COVID-19 on supplemental oxygen or mechanical ventilation with abnormal levels of at least two serum biomarkers, C reactive protein, D dimer, lactate dehydrogenase, or ferritin. Quantum Genomics launched its Phase III REFRESH trial in difficult-to-treat or resistant hypertension.

Trials 52
article thumbnail

CheckMate -577, a Phase 3 Trial Evaluating Opdivo (nivolumab) as Adjuvant Therapy for Patients with Resected Esophageal or Gastroesophageal Junction Cancer, Meets Primary Endpoint of Disease-Free Survival

The Pharma Data

We are developing cancer treatments directed at key biological pathways using our protein homeostasis platform, a research capability that has been the basis of our approved therapies for multiple myeloma and several promising compounds in early- to mid-stage development. It is not known whether OPDIVO or YERVOY is present in human milk.

Trials 52
article thumbnail

CheckMate -649, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Chemotherapy vs. Chemotherapy, Meets Primary Endpoints Demonstrating Superior Overall Survival and Progression-Free Survival in First-Line Treatment of Gastric and Esophageal Cancers

The Pharma Data

We are developing cancer treatments directed at key biological pathways using our protein homeostasis platform, a research capability that has been the basis of our approved therapies for multiple myeloma and several promising compounds in early- to mid-stage development. It is not known whether OPDIVO or YERVOY is present in human milk.

Trials 52